Please Wait
Applying Filters...

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

AKL Research & Development Limited, trading as AKL Therapeutics, is based at the Stevenage Bioscience Catalyst, Stevenage, Herts UK. AKL identifies and synthesizes secondary metabolites of plant origin with proven efficacy & safety. This innovative approach greatly increases the chances of success, while reducing the probability of unexpected side effects. AKL is focused on developing its lead clinical asset APPA, a novel ther...
AKL Research & Development Limited, trading as AKL Therapeutics, is based at the Stevenage Bioscience Catalyst, Stevenage, Herts UK. AKL identifies and synthesizes secondary metabolites of plant origin with proven efficacy & safety. This innovative approach greatly increases the chances of success, while reducing the probability of unexpected side effects. AKL is focused on developing its lead clinical asset APPA, a novel therapeutic for inflammatory diseases where there is a high unmet need, including osteoarthritis (OA) and other complex diseases of ageing.

List your booth number for exhibitions, ask us